Literature DB >> 27406173

Instrument Development in Choice Experiments. Commentary on: "Applying a Framework for Instrument Development of a Choice Experiment to Measure Treatment Preferences in Type 2 Diabetes".

Eve Wittenberg1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27406173     DOI： 10.1007/s40271-016-0186-8

Source DB:  PubMed          Journal:  Patient        ISSN： 1178-1653            Impact factor:   3.883


× No keyword cloud information.
  13 in total

1.  Using Best-Worst Scaling to Measure Caregiver Preferences for Managing their Child's ADHD: A Pilot Study.

Authors:  Susan dosReis; Xinyi Ng; Emily Frosch; Gloria Reeves; Charles Cunningham; John F P Bridges
Journal:  Patient       Date:  2015-10       Impact factor: 3.883

2.  A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy.

Authors:  Holly L Peay; Ilene Hollin; Ryan Fischer; John F P Bridges
Journal:  Clin Ther       Date:  2014-05       Impact factor: 3.393

3.  A best-worst scaling experiment to prioritize caregiver concerns about ADHD medication for children.

Authors:  Melissa Ross; John F P Bridges; Xinyi Ng; Lauren D Wagner; Emily Frosch; Gloria Reeves; Susan dosReis
Journal:  Psychiatr Serv       Date:  2014-11-17       Impact factor: 3.084

4.  Valuing the ICECAP capability index for older people.

Authors:  Joanna Coast; Terry N Flynn; Lucy Natarajan; Kerry Sproston; Jane Lewis; Jordan J Louviere; Tim J Peters
Journal:  Soc Sci Med       Date:  2008-06-21       Impact factor: 4.634

5.  Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force.

Authors:  John F P Bridges; A Brett Hauber; Deborah Marshall; Andrew Lloyd; Lisa A Prosser; Dean A Regier; F Reed Johnson; Josephine Mauskopf
Journal:  Value Health       Date:  2011-04-22       Impact factor: 5.725

6.  Measuring the Preferences of Homeless Women for Cervical Cancer Screening Interventions: Development of a Best-Worst Scaling Survey.

Authors:  Eve Wittenberg; Monica Bharel; Adrianna Saada; Emely Santiago; John F P Bridges; Linda Weinreb
Journal:  Patient       Date:  2015-10       Impact factor: 3.883

7.  Statistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force.

Authors:  A Brett Hauber; Juan Marcos González; Catharina G M Groothuis-Oudshoorn; Thomas Prior; Deborah A Marshall; Charles Cunningham; Maarten J IJzerman; John F P Bridges
Journal:  Value Health       Date:  2016-05-12       Impact factor: 5.725

8.  Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force.

Authors:  F Reed Johnson; Emily Lancsar; Deborah Marshall; Vikram Kilambi; Axel Mühlbacher; Dean A Regier; Brian W Bresnahan; Barbara Kanninen; John F P Bridges
Journal:  Value Health       Date:  2013 Jan-Feb       Impact factor: 5.725

9.  A Framework for Instrument Development of a Choice Experiment: An Application to Type 2 Diabetes.

Authors:  Ellen M Janssen; Jodi B Segal; John F P Bridges
Journal:  Patient       Date:  2016-10       Impact factor: 3.883

10.  Healthcare Worker Preferences for Active Tuberculosis Case Finding Programs in South Africa: A Best-Worst Scaling Choice Experiment.

Authors:  Nathan N O'Hara; Lilla Roy; Lyndsay M O'Hara; Jerry M Spiegel; Larry D Lynd; J Mark FitzGerald; Annalee Yassi; Letshego E Nophale; Carlo A Marra
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240
View more
  2 in total

1.  Art and Science of Instrument Development for Stated-Preference Methods.

Authors:  Ellen M Janssen; John F P Bridges
Journal:  Patient       Date:  2017-08       Impact factor: 3.883

2.  Utilising Patient and Public Involvement in Stated Preference Research in Health: Learning from the Existing Literature and a Case Study.

Authors:  Gemma E Shields; Lindsey Brown; Adrian Wells; Lora Capobianco; Caroline Vass
Journal:  Patient       Date:  2021-07       Impact factor: 3.883
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.